Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma

Lorenzo Falchi; Martin Hutchings; Carmelo Carlo-Stella; Franck Morschhauser; Michael Dickinson; Guillaume Cartron; Cyrus Khan; Monica Tani; Joaquin Martinez-Lopez; Nancy L. Bartlett; Antonio Salar; Joshua D. Brody; Sirpa Leppä; Aurelien Berthier; Martine Kallemeijn; James Relf; Fabiola Bene Tchaleu; Linda Lundberg; Emmanuel Bachy

doi:10.3324/haematol.2024.286257

Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma

Lorenzo Falchi
, Martin Hutchings
, Carmelo Carlo-Stella
, Franck Morschhauser
, Michael Dickinson
, Guillaume Cartron
, Cyrus Khan
, Monica Tani
, Joaquin Martinez-Lopez
, Nancy L. Bartlett
, Antonio Salar
, Joshua D. Brody
, Sirpa Leppä
, Aurelien Berthier
, Martine Kallemeijn
, James Relf
, Fabiola Bene Tchaleu
, Linda Lundberg
, Emmanuel Bachy

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	999-1004
Number of pages	6
Journal	Haematologica
Volume	110
Issue number	4
DOIs	https://doi.org/10.3324/haematol.2024.286257
State	Published - Apr 2025

Access to Document

10.3324/haematol.2024.286257

Cite this

Falchi, L., Hutchings, M., Carlo-Stella, C., Morschhauser, F., Dickinson, M., Cartron, G., Khan, C., Tani, M., Martinez-Lopez, J., Bartlett, N. L., Salar, A., Brody, J. D., Leppä, S., Berthier, A., Kallemeijn, M., Relf, J., Tchaleu, F. B., Lundberg, L., & Bachy, E. (2025). Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma. Haematologica, 110(4), 999-1004. https://doi.org/10.3324/haematol.2024.286257

@article{5f1686db8a2e4e32b00681ac43e1de92,

title = "Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma",

author = "Lorenzo Falchi and Martin Hutchings and Carmelo Carlo-Stella and Franck Morschhauser and Michael Dickinson and Guillaume Cartron and Cyrus Khan and Monica Tani and Joaquin Martinez-Lopez and Bartlett, \{Nancy L.\} and Antonio Salar and Brody, \{Joshua D.\} and Sirpa Lepp{\"a} and Aurelien Berthier and Martine Kallemeijn and James Relf and Tchaleu, \{Fabiola Bene\} and Linda Lundberg and Emmanuel Bachy",

year = "2025",

month = apr,

doi = "10.3324/haematol.2024.286257",

language = "English",

volume = "110",

pages = "999--1004",

journal = "Haematologica",

issn = "0390-6078",

number = "4",

}

Falchi, L, Hutchings, M, Carlo-Stella, C, Morschhauser, F, Dickinson, M, Cartron, G, Khan, C, Tani, M, Martinez-Lopez, J, Bartlett, NL, Salar, A, Brody, JD, Leppä, S, Berthier, A, Kallemeijn, M, Relf, J, Tchaleu, FB, Lundberg, L & Bachy, E 2025, 'Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma', Haematologica, vol. 110, no. 4, pp. 999-1004. https://doi.org/10.3324/haematol.2024.286257

Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma. / Falchi, Lorenzo; Hutchings, Martin; Carlo-Stella, Carmelo et al.
In: Haematologica, Vol. 110, No. 4, 04.2025, p. 999-1004.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma

AU - Falchi, Lorenzo

AU - Hutchings, Martin

AU - Carlo-Stella, Carmelo

AU - Morschhauser, Franck

AU - Dickinson, Michael

AU - Cartron, Guillaume

AU - Khan, Cyrus

AU - Tani, Monica

AU - Martinez-Lopez, Joaquin

AU - Bartlett, Nancy L.

AU - Salar, Antonio

AU - Brody, Joshua D.

AU - Leppä, Sirpa

AU - Berthier, Aurelien

AU - Kallemeijn, Martine

AU - Relf, James

AU - Tchaleu, Fabiola Bene

AU - Lundberg, Linda

AU - Bachy, Emmanuel

PY - 2025/4

Y1 - 2025/4

UR - https://www.scopus.com/pages/publications/105001641823

U2 - 10.3324/haematol.2024.286257

DO - 10.3324/haematol.2024.286257

M3 - Letter

C2 - 39605203

AN - SCOPUS:105001641823

SN - 0390-6078

VL - 110

SP - 999

EP - 1004

JO - Haematologica

JF - Haematologica

IS - 4

ER -

Falchi L, Hutchings M, Carlo-Stella C, Morschhauser F, Dickinson M, Cartron G et al. Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma. Haematologica. 2025 Apr;110(4):999-1004. doi: 10.3324/haematol.2024.286257

Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma

Access to Document

Other files and links

Cite this